High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$249K
$249,985
Total Sells (Filtered)
$2.9M
$2,850,180
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VERA
S
Vera Therapeutics, Inc.
Brenner Robert
• Officer • Chief Medical Officer
Sell to Cover
2026-02-23
$90,307
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-02-23 | $90,307 | S | Form 4 |
| VERA |
Vera Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-23 | $710,578 | S | Form 4 |
| VERA |
Vera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-23 | $207,778 | S | Form 4 |
| VERA |
Vera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-02-23 | $108,276 | S | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Skelton Laurence Matthew
• Officer • Chief Commercial Officer
Sell to Cover
2026-02-23
$66,419
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-02-23 | $66,419 | S | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
Sell to Cover
2026-02-23
$91,819
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
Sell to Cover
|
2026-02-23 | $91,819 | S | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Young Joseph R
• Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Sell to Cover
2026-02-23
$130,864
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Sell to Cover
|
2026-02-23 | $130,864 | S | Form 4 |
|
VERA
M
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
Equity Compensation
2025-12-15
$155,300x2
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
Equity Compensation
|
2025-12-15 | $155,300x2 | M | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
2025-12-15
$500,767
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
|
2025-12-15 | $500,767 | S | Form 4 |
| VERA |
Vera Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-12-11 | $249,985 | P | Form 4 |
|
VERA
M
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
Equity Compensation
2025-12-03
$155,300x2
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
Equity Compensation
|
2025-12-03 | $155,300x2 | M | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
2025-12-03
$400,000
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
10b5-1 SellΔOwn -30.8%
|
2025-12-03 | $400,000 | S | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Carter Jason S
• Officer • Chief Legal Officer
Sell to Cover
2025-11-21
$107,498
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2025-11-21 | $107,498 | S | Form 4 |
|
VERA
M
Vera Therapeutics, Inc.
Young Joseph R
• Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Other
2025-11-13
$39,396
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Other
|
2025-11-13 | $39,396 | M | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Young Joseph R
• Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Discretionary SellΔOwn -23.9%
2025-11-11
$435,874
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Discretionary SellΔOwn -23.9%
|
2025-11-11 | $435,874 | S | Form 4 |